Janssen's Invokana Now Approved to Reduce Risk of Major CV Events

Media coverage

• Title	Janssen's Invokana Now Approved to Reduce Risk of Major CV Events
  Media name/outlet	Research & Development
  Country	United States
  Date	10/31/18
  Persons	Ralph A Defronzo

• Title	Janssen's Invokana Now Approved to Reduce Risk of Major CV Events
  Media name/outlet	PharmaceuticalProcessing
  Country	United States
  Date	10/31/18
  Persons	Ralph A Defronzo